CLINICAL PHARMACY means many things to many people and any definition of the term at this time lies in the eyes of the beholder or the individual practitioner, depending on his personal views of what clinical pharmacy is or is not. Not only has there been a lack of consensus on a definition of clinical pharmacy, but it is the official policy of the American Pharmaceutical Association (APhA) that pharmacy should not be identified as "clinical pharmacy" and pharmacists should not be identified as "clinical pharmacists" at this time. This position is based on the belief that the adjective "clinical" describes functions and that all practitioners should involve themselves in clinical functions. This policy, embodied in a committee report adopted by the APhA House of Delegates in April, 1972, stems from a statement developed by an APhA Task Force on the Definition of Clinical Pharmacy, Institutional Pharmacy and Group Practice .... Most of the support for the statement came from community pharmacists, many of whom perhaps fear that the term "clinical pharmacist" legitimizes a new breed of superpharmacist and places the average practitioner in an inferior position.
Although I agree philosophically with the Task Force statement and the APhA's official position, I recognize that it is a good example of organized pharmacy spitting in the wind. And the wind being created by clinical pharmacy is the briskest that has ever swept the profession.
Gap Between Rhetoric and Practice
... Let's explore some of the basic problems and stumbling blocks that we face in the clinical pharmacy movement. To begin, let's identify several gaps to which the profession must address itself. First, there is the gap between rhetoric and actual practice in a collectivesense. Every profession has its share of spokesmen and practitioners whose words are louder than their deeds. Pharmacy is no exception and the current interest in the concept of clinical pharmacy may, as Parker has put it, be either our salvation or our "Waterloo." The vast majority of pharmacists in the U.S. are not prepared, either by :ducation or experience, nor even attitudinally, to function as true clinical practitioners. These individuals may do more harm than good if they attempt to step up to a new role prematurely. "Goals for Hospital Pharmacy," adopted in 1964 includes the following sentence: "Pharmacy will receivp rofessional recognition from society only to the extent that its practitioners make use of their specialized scientific and professional knowledge."! All of our chestbeating and packaged professional and public relations will have little impact if we can't deliver what we promise ....
Evaluation of Clinical Services Needed
All of which points to the need to critically evaluate, via the scientific method, the effectiveness, including the cost effectiveness, of clinical pharmacy services.... In this era of spiraling health care costs and a proliferation of new categories of health manpower, all of which will be under close scrutiny, we cannot expect our administrators, government and other third parties, and the consumer to support programs that haven't met true tests of value. And whether we like it or not, those tests are going to have to extend far beyond the confines of one institution. They're going to have to be documented in the literature and replicated ina variety of different settings and under a variety of different conditions if widespread progress is to be expected.
The Education Gap
Another gap, one that's certainly related to the performance gap we've already discussed, is the education gap. We've already noted that most pharmacists in current practice are not capable of functioning in a clinical role. What are we going to do about this? Are we to try to elevate these practitioners through continuing education or will we perpetuate two or more classes of pharmacists? If the past is any indication, not many pharmacists, overall, are highly motivated toward continuing education. Although this may be partly because of inadequacies in programs and the inability to participate in traditional continuing education, it would probably be fair to say that the majority of present-day pharmacists are just not interested in expanding their professional and scientific knowledge. We then face the fact that we'll have two or more classesof pharmacistsat least for many years to come. Not only is that a fact in our present circumstances, but at least one prominent pharmaceutical educator suggests fostering of the concept. Dean Jere Goyan of the University of California School of Pharmacy has proposed dividing our colleges of pharmacy into two groups and educating two separate and distinct types of pharmacists. One group of colleges would train "drug delivery specialists" under a four-year B.S. program and the other group would train "drug therapy specialists" under a six-or sevenyear Pharm.D. program. This system would be structured so that four-year pharmacists would have free access into the doctoral program at any time, according to Goyan. Said another way, the dual system would train dispensing pharmacists and clinical pharmacists in separate programs. Those who feel that all pharmacy students should have clinical training will surely take exception to the idea. I like the concept, but calling both of these people "pharmacists" concerns me. Part of nursing's problem is that there are at least three breeds of nurses-the two-year community college associate degree nurse, the three-year hospital diploma school nurse and the four-year university baccalaureate degree nurse. There is something to be learned there that pharmacy should not overlook.
There are at least two possible variations of the Goyan proposal that may merit consideration, however. One would involve a closer look at the proposed four-year pharmacy program to see if it could be reduced to two or three years, in which case we would have a pharmacy technician, or druggist, or whatever we may want to call this individual-something other than pharmacistresponsible for the distribution function, reserving the term pharmacist for the well-trained drug therapy specialist. Another variation would call the lower-level person a pharmacist and the therapy expert a pharmacologist. This latter approach would mean resigning ourselves to the concept of pharmacy as a supply function and the pharmacist as a dispenser and abandoning the term clinical pharmacy by merging it into pharmacology. I believe this direction must be examined. Merging clinical pharmacy and clinical pharmacology and calling it the latter makes some sense from at least three standpoints: (1) it obviates the need to overcome the poor public image associated with the terms "pharmacy" and "pharmacist;" (2) it recognizes the many similarities and overlapping areas of knowledge between the two disciplines; and (3) it follows the concept of functional education in the health professions and opens the door to decision-making roles, e.g., in drug prescribing, for these individuals. A functional approach would mean the individual educated in drug therapy would have complete responsibility and accountability in that area-from prescribing through drug administration and evaluation of therapeutic results.
The difference between "clinical pharmacy" and clinical pharmacology is an intriguing question. The following are some quotations taken from a World Health Organization (WHO) publication entitled "Clinical Pharmacology: Scope, Organization and Training."
The clinical pharmacologist may be concerned with research on the monitoring of adverse effects .... The clinical pharmacologist is also concerned with monitoring the therapeutic use of drugs and the pattern of drug prescribing, including indications, contraindications and suitability. His interests may also involve research in ... errors by patients in following directions for taking drugs and dispensing errors ....
Clinical pharmacologists should play an active part in planning the provision and dissemination of information about drugs.
The analysis of drug levels in body fluids has been shown to be important for the care of individual patients. The clinical pharmacologist has an essential role to play in the practical application of pharmacokinetic data.
Clinical pharmacologists can fulfill an important service by surveying prescribing patterns and the incidenceof adverse reactions. His general pharmacological interests and experience make him the most suitable person to coordinate the detection and quantification of adverse reactions to drugs in hospitals. ' One could substitute the word "pharmacist" for "pharmacologist" in all of the preceding quotations and the publication from which they were taken could easily become a treatise on clinical pharmacy. Clinical pharmacologists, as they are presently defined, are, of course, very rare animals, while pharmacists are much more numerous. Of course we should utilize the pharmacist more effectively if he is overtrained for what he does, but the shortage of clinical pharmacologists and the vast areas of overlap between him and the clinical pharmacist are all the more reason to consider combining the disciplines. Whether this will ever happen may rest with future generations. In the meantime, it should hardly dampen our enthusiasm to carve a more meaningful role for pharmacy in health care.
Environment of Clinical Pharmacy Practice
One issue that has caused a bit of stir since the clinical pharmacy concept has come into vogue is whether clinical pharmacy is tied to environment of practice. Hospital pharmacists and the ASHP have been accused of taking the position that clinical pharmacy and hospital pharmacy are synonymous and that clinical pharmacy can be practiced only in the institutional environment. The Society has repeatedly disclaimed any intention of promoting such a direct association while pointing out that environment can nevertheless have a decided influence on function. Again we're faced with a question of definition and the question of whether clinical pharmacy is a direction the entire profession is taking or a specialty area of practice. The APhA's reluctance to sanction the term clinical pharmacy is understandable if we consider it to be an emerging specialty and, as such, difficult or impossible to practice anywhere except in a multidisciplinary environment-or said another way, impossible to practice in an isolated setting such as a traditional community pharmacy. In a paper presented at the first annual meeting of the American College of Clinical Pharmacology, Don Francke stated whom he meant in referring to a clinical pharmacist:
He is an individual with two years of education and training beyond the bachelor's degree .... During these two years, he has taken additional courses in biopharmaceutics and pharmacokinetics beyond those he has had in his undergraduate work. He has had at least a semester of graduate levelbiostatistics. He has taken additional courses in pharmacology equivalent to those given to medical and graduate students. He has had a graduate level course in pathology .... 3 Francke makes it clear elsewhere in the paper that he is talking about a practitioner with a Pharm.D. degree. The preface to "Perspectives in Clinical Pharmacy," a book by Francke and Whitney, has this to say:
Fortunately, no one has yet succeeded in defining clinical pharmacy and it thus remains an evolving concept with great promise. When the concept finally matures, we believe that the clinical pharmacist will perhaps best be described as an applied pharmacology generalist." (Italics added.) ' If we accept Francke's definition of a clinical pharmacist, there's no question that we're talking about a specialist. And it's difficult to picture this seven-year graduate practicing anywhere but in a structured system such as a hospital or health center where he'll have access to the patient's medical history and records, and be in direct contact on a day-to-day basis with other health professionals. Thus, if clinical pharmacy is now or is going to be a specialty, pharmacy had better stop kidding itself that it can be practiced anywhere. Further, if we accept the specialty concept rather than the concept of overall direction, and if we buy the description of the clinical pharmacist as an "applied pharmacology generalist," we have what to me appears to be an incongruous situation-a pharmacy specialist-pharmacology generalist. Perhaps this reinforces the need to consider combining the two disciplines under one label. ...
Scientific Foundation For Clinical Pharmacy
Another point we must recognize is that the vast majority of self-proclaimed clinical pharmacists are in reality "generalists" operating without the benefit of a well-defined body of scientific knowledge or techniques distinctly recognized as belonging to "clinical pharmacy." I believe we need to build a sound scientific foundation for clinical pharmacy if we expect it to emerge into a distinct specialty of practice. Taking a thorough drug history, developing and monitoring a patient drug profile, providing drug information, instructing patients on proper use of medications, and monitoring adverse drug reactions and drug utilization EDITORIALS are certainly important aspects of the clinical concept, but they are not enough. Applying the elements of pharmacology, toxicology, biopharmaceutics and pharmacokinetics to clinical pharmacy will be necessary to impart true substance to its practice. A very few practitioners in a very few hospitals are practicing in this kind of depth.
The rigorous preparation required for a more sophisticated clinical pharmacy practice raises another problem, one that the profession has almost totally ignored up to this time. It has been said that the quality control in an educational system is who gets in. Although the caliber of pharmacy student seems to have improved in recent years and we have generated many bright, young practitioners, it is my impression that at least some schools are admitting, carrying and graduating students who really can't cut the mustard. More stringent entrance requirements and less reluctance on the part of schools to drop students are in order.
